4-166735014-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001040159.2(SPOCK3):c.1209C>A(p.Asp403Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000493 in 1,562,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001040159.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPOCK3 | NM_001040159.2 | c.1209C>A | p.Asp403Glu | missense_variant | 11/11 | ENST00000357545.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPOCK3 | ENST00000357545.9 | c.1209C>A | p.Asp403Glu | missense_variant | 11/11 | 1 | NM_001040159.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150598Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246838Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133690
GnomAD4 exome AF: 0.0000517 AC: 73AN: 1411556Hom.: 0 Cov.: 24 AF XY: 0.0000454 AC XY: 32AN XY: 705166
GnomAD4 genome AF: 0.0000266 AC: 4AN: 150598Hom.: 0 Cov.: 32 AF XY: 0.0000409 AC XY: 3AN XY: 73388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2023 | The c.1218C>A (p.D406E) alteration is located in exon 12 (coding exon 11) of the SPOCK3 gene. This alteration results from a C to A substitution at nucleotide position 1218, causing the aspartic acid (D) at amino acid position 406 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at